Enimmune

Enimmune EBIT per Share

The EBIT per Share of Enimmune (6564.TWO) as of Oct 21, 2026 is -2.59 TWD. In the previous year, EBIT per Share was -2.12 TWD — a change of 22.44% (lower).

EBIT per Share

-2.59TWD

YoY

22.44%

Last updated:

EBIT per Share of Enimmune is 2025 -2.59 TWD. EBIT per Share of Enimmune was 2024 -2.12 TWD. It decreases by 22.44% lower compared to the previous year.

The Enimmune EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-2.44 TWD
Jan 1, 2019
-1.63 TWD
Jan 1, 2020
-1.54 TWD
Jan 1, 2021
-0.97 TWD
Jan 1, 2022
-4.35 TWD
Jan 1, 2023
-3.70 TWD
Jan 1, 2024
-2.12 TWD
Jan 1, 2025
-2.59 TWD
The Enimmune EBIT per Share history
YEAREBIT per ShareYoY
-2.59TWD+22.44%
-2.12TWD-42.83%
-3.70TWD-14.99%
-4.35TWD+346.63%
-0.97TWD-36.85%
-1.54TWD-5.19%
-1.63TWD-33.19%
-2.44TWD+168.39%
-0.91TWD-45.34%
-1.66TWD+56.31%
-1.06TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Enimmune Stock analysis

What does Enimmune do? Enimmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enimmune stock

EBIT per Share of Enimmune is -2.59 TWD in 2025.

EBIT per Share of Enimmune changed from -2.12 TWD to -2.59 TWD, representing a 22.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Enimmune since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Enimmune

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Enimmune